Mood stabilizers in pregnancy: a systematic review.
Galbally
Megan
M
Mercy Hospital for Women, Heidelberg, Victoria, Australia. MGalbally@mercy.com.au
Roberts
Matthew
M
Buist
Anne
A
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000077213:Lamotrigine; D016651:Lithium Carbonate / Q000009:adverse effects / Q000627:therapeutic use; D019964:Mood Disorders / Q000150:complications / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000523:psychology; D011256:Pregnancy Outcome; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D014227:Triazines / Q000009:adverse effects / Q000627:therapeutic use
D000928:Antidepressive Agents; D018692:Antimanic Agents; D011619:Psychotropic Drugs; D014227:Triazines; D016651:Lithium Carbonate; D002220:Carbamazepine; D000077213:Lamotrigine